Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age

Running, not enrolling · Phase 3 · Has a placebo group

Conditions studied: Allergy, Peanut

In brief

The primary purpose of this study is to assess the efficacy and safety of daily DBV712 250 micrograms (mcg) to induce desensitization to peanut in peanut-allergic children 4-7 years of age over a 12-month double-blind, placebo-controlled (DBPC) Treatment Period.

Key facts

Study ID

NCT05741476

Run by

DBV Technologies

People needed

600

Starts

2023-02-21

Expected to finish

2029-10-01

Last updated by the study team

2026-01-22

Who can join

Age: 4 and older, up to 7. Sex: any. Healthy volunteers: not accepted.

Where it is running

• DBV Investigative Site — Parkville, Australia
• DBV Investigative Site — Richmond, Australia
• DBV Investigative Site — Birmingham, Alabama, United States
• DBV Investigative Site — Tucson, Arizona, United States
• DBV Investigative Site — Little Rock, Arkansas, United States
• DBV Investigative Site — Los Angeles, California, United States
• DBV Investigative Site — Los Angeles, California, United States
• DBV Investigative site — Mission Viejo, California, United States
• DBV Investigative Site — San Diego, California, United States
• DBV Investigative Site — San Francisco, California, United States
• DBV Investigative Site — San Jose, California, United States
• DBV Investigative Site — Aurora, Colorado, United States
• DBV Investigative Site — Colorado Springs, Colorado, United States
• DBV Investigative Site — Washington D.C., District of Columbia, United States
• DBV Investigative Site — Hollywood, Florida, United States
• DBV Investigative Site — Miami, Florida, United States
• DBV Investigative Site — St. Petersburg, Florida, United States
• DBV Investigative Site — Tampa, Florida, United States
• DBV Investigative site — Atlanta, Georgia, United States
• DBV Investigative Site — Marietta, Georgia, United States
• DBV Investigative Site — Chicago, Illinois, United States
• DBV Investigative Site — Normal, Illinois, United States
• DBV Investigative Site — Indianapolis, Indiana, United States
• DBV Investigative Site — Louisville, Kentucky, United States
• DBV Investigative Site — Nedlands, Australia

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.